Nu-Med Plus (NUMD) Notes Payables (2012 - 2025)
Nu-Med Plus recorded quarterly Notes Payables of $100000.0 in Q4 2025, little changed quarter-over-quarter from $100000.0 in Q3 2025, and little changed year-over-year from $100000.0 in Q4 2024.
Nu-Med Plus' Notes Payables history runs 13 years deep, the most recent figure standing at $100000.0 for Q4 2025.
- In Q4 2025, Notes Payables changed 0.0% year-over-year to $100000.0; the TTM figure through Dec 2025 stood at $100000.0 (changed 0.0% YoY), while the FY2025 annual figure was $100000.0, changed 0.0% from the prior year.
- Notes Payables came in at $100000.0 for Q4 2025 at Nu-Med Plus, roughly flat from $100000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $100000.0 in Q4 2022 to a low of $100000.0 in Q4 2022.
- A 4-year average of $100000.0 and a median of $100000.0 in 2022 frame the typical range for Notes Payables.
- On a YoY basis, Notes Payables climbed as much as 0.0% in 2023 and fell as far as 0.0% in 2023.
- Nu-Med Plus' Notes Payables stood at $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
- According to Business Quant data, Notes Payables over the past three periods registered $100000.0, $100000.0, and $100000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2020 | 230,100.00 |
| Jun 30, 2020 | 230,100.00 |
| Mar 31, 2020 | 230,100.00 |
| Dec 31, 2019 | 230,100.00 |
| Sep 30, 2019 | 230,100.00 |
| Jun 30, 2019 | 230,100.00 |
| Mar 31, 2019 | 230,100.00 |
| Dec 31, 2018 | 230,100.00 |
| Sep 30, 2018 | 230,100.00 |
| Jun 30, 2018 | 230,100.00 |
| Mar 31, 2018 | 230,100.00 |
| Dec 31, 2017 | 230,100.00 |
| Sep 30, 2017 | 309,910.00 |
| Jun 30, 2017 | 309,910.00 |
| Mar 31, 2017 | 309,910.00 |
| Dec 31, 2016 | 315,902.00 |
| Sep 30, 2016 | 255,309.00 |
| Jun 30, 2016 | 248,433.00 |
| Mar 31, 2016 | 241,558.00 |
| Dec 31, 2015 | 211,767.00 |
| Sep 30, 2015 | 230,100.00 |
| Jun 30, 2015 | 230,100.00 |
| Mar 31, 2015 | 230,100.00 |
| Dec 31, 2014 | 230,100.00 |
| Sep 30, 2014 | 230,100.00 |
| Jun 30, 2014 | 230,100.00 |
| Mar 31, 2014 | 230,100.00 |
| Dec 31, 2013 | 199,384.00 |
| Sep 30, 2013 | 166,136.00 |
| Jun 30, 2013 | 100,000.00 |
| Mar 31, 2013 | 100,000.00 |
| Dec 31, 2012 | 100,000.00 |